Octreotide clinical trials: 71 trials
Page 1 of 2
Read 71 Octreotide clinical trials with posted results or linked papers with results in PepBank.
- Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding
NCT00966355 · Phase 4 · Completed
Posted results
- Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor
NCT00412061 · Phase 3 · Completed
Posted results
- Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
NCT00569127 · Phase 3 · Active, not recruiting
Posted results
- Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
NCT00600886 · Phase 3 · Completed
Posted results
- Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas
NCT01744249 · Phase 2/3 · Completed
Posted results
- A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours
NCT01578239 · Phase 3 · Completed
Posted results
- Study to Evaluate the Efficacy and Safety of Lutathera in Patients With Grade 2 and Grade 3 Advanced GEP-NET
NCT03972488 · Phase 3 · Active, not recruiting
Posted results
- Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly
NCT01137682 · Phase 3 · Completed
Posted results
- Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease
NCT00690430 · Phase 3 · Completed
Posted results
- Efficacy and Safety of Octreotide (MYCAPSSA™ [Formerly Octreolin™]) for Acromegaly
NCT01412424 · Phase 3 · Completed
Posted results
- Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
NCT02685709 · Phase 3 · Completed
Posted results
- Evaluation of Octreotide LAR in Prevention of Chemotherapy-induced Diarrhea
NCT00582426 · Phase 3 · Completed
Posted results
- Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut
NCT00171873 · Phase 3 · Completed
Posted results
- A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
NCT04076462 · Phase 3 · Completed
Posted results
- A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD
NCT05281328 · Phase 2/3 · Active, not recruiting
Posted results
- Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients
NCT01278342 · Phase 4 · Completed
Posted results
- Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly
NCT03252353 · Phase 3 · Status unknown
Posted results
- A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide
NCT03289741 · Phase 4 · Completed
Posted results
- Octreotide in Severe Polycystic Liver Disease
NCT00426153 · Phase 2/3 · Completed
Posted results
- Surgical Debulking of Pituitary Adenomas
NCT01371643 · Phase 4 · Completed
Posted results
- Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices
NCT03624517 · Phase 4 · Terminated
Posted results
- Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
NCT01789281 · Phase 4 · Completed
Posted results
- Octreotide in Treating Patients With Cancer-Related Malignant Ascites
NCT00182754 · Phase 3 · Completed
Posted results
- Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis
NCT00108355 · Phase 4 · Completed
Posted results
- Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly
NCT00372697 · Phase 3 · Completed
Posted results
- Effects of Sandostatin LAR® in Acromegaly
NCT01424241 · Phase 4 · Completed
Posted results
- Ultrasound Guided Octreotide LAR Injection in Acromegaly
NCT00552071 · Phase 4 · Completed
Posted results
- Effect of Octreotide on the Colonic Motility in Pediatric Patients
NCT01917773 · Phase 4 · Completed
Posted results
- Comparison of 2 Days Versus 5 Days of Octreotide After Endoscopic Therapy in Preventing Early Esophageal Varices Rebleed : A Randomized Controlled Study
NCT05199038 · Phase 4 · Status unknown
Linked paper with results
- Role of Octreotide in Preventing Pancreatic Fistula After Pancreaticoduodenectomy (PD) in Patients With Soft Pancreas
NCT01301222 · Phase 4 · Completed
Linked paper with results
- Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency
NCT01377246 · Phase 3 · Completed
Linked paper with results
- Preoperative Octreotide Treatment of Acromegaly
NCT00521300 · Phase 4 · Completed
Linked paper with results
- Functional MRI-based Assessment of Terlipressin vs. Octreotide on Renal Function in Cirrhotic Patients With Acute Variceal Bleeding (CHESS1903)
NCT04028323 · Phase 4 · Status unknown
Linked paper with results
- Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly
NCT00461149 · Phase 4 · Completed
Linked paper with results
- The Effect of Octreotide on Wound Drainage After Mastectomy
NCT05682209 · Phase 4 · Completed
Linked paper with results
- GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma
NCT00495846 · Phase 2/3 · Completed
Linked paper with results
- GA-68 DOTA-TOC of Somatostatin Positive Malignancies
NCT02177773 · Phase 1/2 · Terminated
Posted results
- Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy
NCT00363051 · Phase 2 · Completed
Posted results
- Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery
NCT01229943 · Phase 2 · Completed
Posted results
- Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT
NCT01869725 · Phase 2 · Completed
Posted results
- RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
NCT00113360 · Phase 2 · Completed
Posted results
- Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis
NCT00332696 · Phase 2 · Completed
Posted results
- Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer
NCT02294786 · Phase 2 · Terminated
Posted results
- AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
NCT00427349 · Phase 2 · Completed
Posted results
- A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors
NCT02795858 · Phase 2 · Completed
Posted results
- A Study of Cixutumumab (IMC-A12) in Islet Cell Cancer
NCT00781911 · Phase 2 · Completed
Posted results
- Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers
NCT01121939 · Phase 2 · Completed
Posted results
- Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC)
NCT03273712 · Phase 2 · Completed
Posted results
- Trial Using Octreotide to Enhance Liver Recovery After Hepatectomy
NCT03179995 · Phase 2 · Terminated
Posted results
- Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy
NCT00853047 · Phase 2 · Completed
Posted results